Tongling Jieya Biologic Technology Hits Day Low Amid Price Pressure at CNY 27.02

Tongling Jieya Biologic Technology Co., Ltd. experienced a significant decline today, with the stock dropping by 7.07% as it reached an intraday low of CNY 27.02. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Tongling Jieya has seen a decline of 11.48%, and its monthly performance reflects a drop of 15.78%. Despite these short-term challenges, the company has shown resilience over the past year, boasting a return of 41.04%, significantly outperforming the China Shanghai Composite's 13.33% gain. Financially, Tongling Jieya reported a remarkable net profit growth of 336.33% in September, alongside record net sales of CNY 254.65 million and operating profit of CNY 33.34 million. The company has also benefited from a substantial reduction in raw material costs, which fell by 79.52% year-over-year. With a market capitalization of CNY 2,089 million, Tongling Jieya operates within the FMCG sector and maintains a price-to-book ratio of 1.89, indicating a fair valuation in the current market landscape.